Total Payments
$2,174
2024 Payments
$42.14
Companies
12
Transactions
29
Medicare Patients
6,722
Medicare Billing
$290,820
Payment Breakdown by Category
Other$1,701 (78.2%)
Food & Beverage$473.57 (21.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $1,701 | 2 | 78.2% |
| Food and Beverage | $473.57 | 27 | 21.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,701 | 2 | $0 (2021) |
| Amgen Inc. | $127.00 | 6 | $0 (2022) |
| Amneal Pharmaceuticals LLC | $76.56 | 5 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $70.38 | 5 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $33.00 | 1 | $0 (2019) |
| Novo Nordisk Inc | $32.86 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $32.31 | 2 | $0 (2022) |
| ABBVIE INC. | $28.00 | 1 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $27.27 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $19.49 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.14 | 2 | ABBVIE INC. ($28.00) |
| 2022 | $207.02 | 11 | Amgen Inc. ($95.82) |
| 2021 | $1,735 | 4 | Abbott Laboratories ($1,701) |
| 2020 | $115.22 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($45.93) |
| 2019 | $57.45 | 3 | Janssen Pharmaceuticals, Inc ($33.00) |
| 2018 | $17.49 | 1 | Merck Sharp & Dohme Corporation ($17.49) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/15/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: Pain Management | ||||||
| 12/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes | ||||||
| 09/22/2022 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROLOGY | ||||||
| 09/06/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Inflammation | ||||||
| 06/21/2022 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROLOGY | ||||||
| 06/02/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Inflammation | ||||||
| 04/28/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Inflammation | ||||||
| 03/10/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), JANUVIA, VERQUVO | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Diabetes | ||||||
| 02/10/2022 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Neuroscience | ||||||
| 12/16/2021 | Abbott Laboratories | — | Debt forgiveness | Cash or cash equivalent | $1,084.50 | General |
| 12/16/2021 | Abbott Laboratories | — | Debt forgiveness | Cash or cash equivalent | $616.14 | General |
| 09/23/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Inflammation | ||||||
| 03/02/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device), REYVOW | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/09/2020 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/01/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Neuroscience | ||||||
| 10/28/2020 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 09/16/2020 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROLOGY | ||||||
| 09/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 221 | 454 | $12,443 | $7,656 |
| 2022 | 24 | 1,564 | 3,724 | $145,497 | $74,247 |
| 2021 | 26 | 2,395 | 5,931 | $230,304 | $113,591 |
| 2020 | 26 | 2,542 | 6,381 | $226,895 | $95,325 |
Total Patients
6,722
Total Services
16,490
Medicare Billing
$290,820
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 43 | $5,590 | $3,598 | 64.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 54 | $4,860 | $3,368 | 69.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 53 | $1,325 | $526.32 | 39.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 22 | $110.00 | $107.80 | 98.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 34 | 114 | $228.00 | $40.61 | 17.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 35 | 168 | $330.00 | $15.94 | 4.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 676 | $80,876 | $51,156 | 63.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 205 | $16,504 | $8,192 | 49.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 179 | 339 | $10,227 | $2,743 | 26.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 56 | 58 | $5,046 | $2,024 | 40.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 43 | 90 | $2,514 | $1,470 | 58.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 26 | 47 | $1,964 | $1,393 | 70.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 15 | 20 | $2,855 | $1,039 | 36.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 96 | 107 | $2,853 | $825.23 | 28.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 17 | 19 | $1,060 | $724.52 | 68.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 56 | 75 | $3,856 | $722.22 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,309 | $668.24 | 51.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 26 | 34 | $2,924 | $606.59 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 132 | 175 | $1,298 | $520.08 | 40.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 16 | 16 | $496.00 | $479.52 | 96.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 23 | 34 | $2,400 | $425.72 | 17.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 29 | 66 | $644.00 | $331.58 | 51.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 58 | 79 | $1,072 | $173.17 | 16.2% |
| 85610 | Blood test, clotting time | Office | 2022 | 15 | 40 | $642.00 | $169.30 | 26.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 133 | 574 | $4,092 | $165.31 | 4.0% |
About Dr. Robert Davis, MD
Dr. Robert Davis, MD is a Family Medicine healthcare provider based in Vernon, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992741284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Davis, MD has received a total of $2,174 in payments from pharmaceutical and medical device companies, with $42.14 received in 2024. These payments were reported across 29 transactions from 12 companies. The most common payment nature is "Debt forgiveness" ($1,701).
As a Medicare-enrolled provider, Davis has provided services to 6,722 Medicare beneficiaries, totaling 16,490 services with total Medicare billing of $290,820. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Vernon, AL
- Active Since 06/22/2006
- Last Updated 03/21/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992741284
Products in Payments
- Otezla (Drug) $90.26
- RYTARY (Drug) $76.56
- XIFAXAN (Drug) $70.38
- Aimovig (Biological) $36.74
- INVOKANA (Drug) $33.00
- Ozempic (Drug) $32.86
- VRAYLAR (Drug) $28.00
- TRELEGY ELLIPTA (Drug) $19.49
- JANUVIA (Drug) $17.49
- BELSOMRA (Drug) $14.82
- COLOGUARD DNA CAPTURE REAGENTS (Device) $14.30
- LIVALO (Drug) $14.14
- Seglentis (Drug) $13.13
- TRULICITY (Drug) $12.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Vernon
Kristin Giannini, M.d, M.D
Family Medicine — Payments: $32,450
Family Medicine $32,450
Mr. Eric Camyre, D.o, D.O
Family Medicine — Payments: $29,591
Family Medicine $29,591
Lisa Talati, Do, DO
Family Medicine — Payments: $27,068
Family Medicine $27,068
Momina Afrede, Do, DO
Family Medicine — Payments: $5,849
Family Medicine $5,849
Dr. Lynne Digennaro, Md, MD
Family Medicine — Payments: $2,611
Family Medicine $2,611
Monique Martin, Md, MD
Family Medicine — Payments: $1,853
Family Medicine $1,853